arrow
返回
M

Ming Dai

Shenzhen Polytechnic University

17H指数
152论文数
1.2K被引数
收录论文 26
发表时间
Relation model-assisted multi-region evolutionary algorithm for expensive constrained optimization关系模型辅助的多区域进化算法用于昂贵约束优化
err2026-03-14
err0
PREAI
errYuxi Huang; Genghui Li; Ming Dai; Laizhong Cui; Wangjun Chen; Zhicai Zhu; Yuchao Su; Qiuzhen Lin; Ka-Chun Wong
err分享
err收藏
err分享
err收藏
err分享
err收藏
Robust Transmission Design for RIS-Aided Wireless Communication With Both Imperfect CSI and Transceiver Hardware Impairments
err2023-03-01
err13
PREAI
errZheng, Hongxia; Pan, Cunhua; Zhang, Chiya; Li, Xingquan; He, Chunlong; Yatao, Yang; Dai, Ming
err分享
err收藏
Electroacupuncture for motor dysfunction and constipation in patients with Parkinson?s disease: a randomised controlled multi-centre trial
err2023-02-01
err29
errOAAI
errLi, Kunshan; Xu, Shifen; Wang, Ruiping; Zou, Xuan; Liu, Huirong; Fan, Chunhai; Li, Jing; Li, Guona; Wu, Yiwen; Ma, Xiaopeng; Chen, Yiyi; Hu, Chenfang; Liu, Xiru; Yuan, Canxing; Ye, Qing; Dai, Ming; Wu, Luyi; Wang, Zhaoqin; Wu, Huangan
err分享
err收藏
err分享
err收藏
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib plus capecitabine (N plus C) vs lapatinib plus capecitabine (L plus C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensNALA试验中泛亚洲患者亚组的分析: 一项随机III期NALA试验,比较了HER2转移性乳腺癌 (mBC) 患者中奈拉替尼加卡培他滨 (N加C) 与拉帕替尼加卡培他滨 (L加C) 先前接受过两种或多种HER2-directed方案治疗的患者
err2021-09-23
err16
errOAAI
errDai, Ming Shen; Feng, Yin Hsun; Chen, Shang Wen; Masuda, Norikazu; Yau, Thomas; Chen, Shou Tung; Lu, Yen Shen; Yap, Yoon Sim; Ang, Peter C. S.; Chu, Sung Chao; Kwong, Ava; Lee, Keun Seok; Ow, Samuel; Kim, Sung Bae; Lin, Johnson; Chung, Hyun Cheol; Ngan, Roger; Kok, Victor C.; Rau, Kun Ming; Sangai, Takafumi; Ng, Ting Ying; Tseng, Ling Ming; Bryce, Richard; Bebchuk, Judith; Chen, Mei Chieh; Hou, Ming Feng
err分享
err收藏
Neratinib plus capecitabine (N plus C) vs lapatinib plus capecitabine (L plus C) in Asians with HER2+metastatic breast cancer (MBC) previously treated with two or more HER2-directed regimens: A Pan-Asian analysis of the phase III NALA trial
err2020-11-01
err0
errOAAI
errDai, M. S.; Feng, Y. H.; Chen, S. W.; Masuda, N.; Sangai, T.; Yau, T.; Kwong, A.; Ngan, R.; Yap, Y. S.; Ang, P. C. S.; Ow, S.; Lee, K. S.; Kim, S. B.; Chung, H. C.; Keyvanjah, K.; Bebchuk, J.; Chen, M-C. J.
err分享
err收藏
A B-Scan Imaging Method of Conductivity Variation Detection for Magneto-Acousto-Electrical Tomography磁声电层析成像电导率变化检测的B扫描成像方法
err2019-01-01
err16
errOAAI
errDai, Ming; Sun, Tong; Chen, Xin; Yu, Lingyao; Chen, Mian; Hao, Penghui; Zeng, Xin; Yan, Jiejie; Chen, Siping
err分享
err收藏
err分享
err收藏
Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer
errEJSO
IF2.9
err2017-10-01
err5
PREAI
errLiao, G. -S.; Dai, M. -S.; Hsu, H. -M.; Chu, C. -H.; Hong, Z. -J.; Fu, C. -Y.; Chou, Y. -C.; Huang, T. -C.; Yu, J. -C.
err分享
err收藏